Literature DB >> 8314530

Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study)

H D Homesley1, B N Bundy, A Sedlis, E Yordan, J S Berek, A Jahshan, R Mortel.   

Abstract

From 1977 to 1984 the Gynecologic Oncology Group (GOG) conducted a prospective clinical and surgical staging protocol of squamous cell carcinoma of the vulva (n = 637). The patients with superficial (5 mm or less invasion) lesions were the subject of a previous report (n = 272). The subject of this report is on factors that predict groin node metastasis based on all 588 evaluable patients. Comparisons between the two reports are made. Almost half of this group (49.3%) had minimal tumor thickness (< or = mm). Almost one-third of patients had small vulvar lesions (< or = cm). Groin node metastasis was 18.9% for the < or = 2-cm diameter tumors and 41.6% for the > 2-cm diameter lesions. The inaccuracy of clinical palpation of the groin nodes (23.9% false negative) largely accounts for underestimation of extent of disease. Body weight was not related to the sensitivity of detecting positive groin nodes (P = 0.26). Using the logistic model, independent predictors of positive groin nodes were identified (in order of importance): less tumor differentiation by GOG criteria (P < 0.0001), suspicious or fixed/-ulcerated nodes (P < 0.0001), presence of capillary-lymphatic involvement (P < 0.0001), older age (P = 0.0002), and greater tumor thickness (invasion) (P = 0.03). Lesion size and location were not independent predictors of positive groin nodes.

Entities:  

Mesh:

Year:  1993        PMID: 8314530     DOI: 10.1006/gyno.1993.1127

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  24 in total

1.  Lymphatic mapping for vulvar cancer: ready for "prime-time?".

Authors:  Robert L Coleman
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

Review 2.  "Unresectable" vulval cancers: is neoadjuvant chemotherapy the way forward?

Authors:  Kathryn Graham; Kevin Burton
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

3.  Management of patients with vulvar cancer: a perspective review according to tumour stage.

Authors:  Linn Woelber; Fabian Trillsch; Lilli Kock; Donata Grimm; Cordula Petersen; Matthias Choschzick; Fritz Jaenicke; Sven Mahner
Journal:  Ther Adv Med Oncol       Date:  2013-05       Impact factor: 8.168

4.  Validation of a nomogram for predicting outcome of vulvar cancer patients, primarily treated by surgery, in Korean population: multicenter retrospective study through Korean Gynecologic Oncology Group (KGOG-1010).

Authors:  Mi-Kyung Kim; Jae Weon Kim; Jong-Min Lee; Nak-Woo Lee; Moon-Seok Cha; Byoung-Gie Kim; Ki Heon Lee; Young-Tae Kim; Jae-Hoon Kim; Eun-Seop Song; Moon-Hong Kim; Sang-Young Ryu; Won Gyu Kim; Young-Tak Kim; Kyung-Tai Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

5.  Preliminary experience of performing a video endoscopic inguinal lymphadenectomy using a hypogastric subcutaneous approach in patients with vulvar cancer.

Authors:  He Wang; Li Li; Desheng Yao; Fei Li; Jieqing Zhang; Zhijun Yang
Journal:  Oncol Lett       Date:  2014-12-02       Impact factor: 2.967

6.  Defining the concept of locally advanced squamous cell carcinoma of the vulva: a new perspective based on standardization of criteria and current evidence.

Authors:  Alejandro M Aragona; Alejandro H Soderini; Nicasio A Cuneo
Journal:  J Gynecol Oncol       Date:  2014-07-06       Impact factor: 4.401

7.  Utility of Intraoperative Fluorescence Imaging in Gynecologic Surgery: Systematic Review and Consensus Statement.

Authors:  Ignacio Zapardiel; Julio Alvarez; Manel Barahona; Pere Barri; Ana Boldo; Pera Bresco; Isabel Gasca; Ibon Jaunarena; Ali Kucukmetin; Gloria Mancebo; Borja Otero; Fernando Roldan; Ramón Rovira; Enma Suarez; Alvaro Tejerizo; Anna Torrent; Mikel Gorostidi
Journal:  Ann Surg Oncol       Date:  2020-10-23       Impact factor: 5.344

8.  Prognostic analysis of early-stage squamous cell carcinoma of the vulva.

Authors:  Li-Qun Xu; Rong-Zhen Luo; Xue-Ming Sun; Jie-Hua He; Yan-Na Zhang
Journal:  World J Surg Oncol       Date:  2013-01-26       Impact factor: 2.754

9.  Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer.

Authors:  Jacek J Sznurkowski; Tomasz Milczek; Janusz Emerich
Journal:  Arch Gynecol Obstet       Date:  2012-12-22       Impact factor: 2.344

10.  Prognostic factors associated with local recurrence in squamous cell carcinoma of the vulva.

Authors:  Sara Iacoponi; Ignacio Zapardiel; Maria Dolores Diestro; Alicia Hernandez; Javier De Santiago
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.